Disc Medicine - Best comparison stock to Clinuvel, page-20

On the Axe thread reference given to market strength mostly in top 50 or 100 stocks. Look at CSL, COH, RMD, CBA and large miners and it tells a story IMO. Underneath that it looks hard going, particularly small cap and as we know biotechs. Shorters or market computer day traders mostly controlling trades in a lot of these stocks (not to mention Li). Anyway, CUV sits just below top stocks IMO - reasonable financials, stable board and management (for now) and relatively low PE. PW stated it only takes one strategic investor to move the price much higher. If he starts ticking those boxes it should happen. I still think a buyback is down the list - 1. Buy something, 2. use the funds conservatively to fund further programs without CR, pay me an interum dividend and 4. yes if the price drops below $14, institute a buyback (but it will probably only give temporary relief from shorters (unless CUV get something else going). I hope the half yearly outdoes expectations and soon after we get a significant update - maybe a box ticked? GLTA